Lupin’s Dabhasa plant gets TGA GMP certification; Pithampur units receive FDA Form-483s with observations after inspections.

• Dabhasa API facility certified by Australia’s TGA, enhancing Lupin’s global pharmaceutical manufacturing credibility.
• Pithampur Unit-3 inspection ended with three observations; Unit-2 faced four, as per U.S. FDA Form-483s.
• Lupin is committed to addressing issues, maintaining CGMP standards across facilities while expanding global contract manufacturing services.